Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 39% ± 17% | |
brain | 18 studies | 33% ± 16% | |
peripheral blood | 16 studies | 37% ± 11% | |
intestine | 11 studies | 35% ± 19% | |
eye | 11 studies | 35% ± 14% | |
kidney | 9 studies | 34% ± 13% | |
lymph node | 6 studies | 37% ± 18% | |
pancreas | 5 studies | 64% ± 28% | |
bone marrow | 5 studies | 31% ± 10% | |
heart | 5 studies | 20% ± 6% | |
uterus | 5 studies | 45% ± 16% | |
liver | 5 studies | 42% ± 22% | |
placenta | 4 studies | 39% ± 16% | |
prostate | 4 studies | 41% ± 13% | |
breast | 4 studies | 49% ± 6% | |
adipose | 4 studies | 21% ± 7% | |
adrenal gland | 3 studies | 37% ± 13% | |
esophagus | 3 studies | 51% ± 29% | |
skin | 3 studies | 37% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14794.77 | 1445 / 1445 | 100% | 498.99 | 183 / 183 |
ovary | 100% | 13718.78 | 180 / 180 | 100% | 456.92 | 430 / 430 |
stomach | 100% | 9699.05 | 359 / 359 | 100% | 336.38 | 286 / 286 |
brain | 100% | 16844.74 | 2640 / 2642 | 100% | 502.59 | 705 / 705 |
breast | 100% | 13039.01 | 459 / 459 | 100% | 427.38 | 1116 / 1118 |
prostate | 100% | 11236.47 | 245 / 245 | 100% | 441.03 | 501 / 502 |
uterus | 100% | 15692.20 | 170 / 170 | 100% | 420.45 | 458 / 459 |
lung | 100% | 11815.20 | 576 / 578 | 100% | 416.45 | 1155 / 1155 |
intestine | 100% | 13331.37 | 966 / 966 | 100% | 334.00 | 525 / 527 |
pancreas | 100% | 9262.18 | 328 / 328 | 99% | 247.41 | 177 / 178 |
bladder | 100% | 12692.05 | 21 / 21 | 99% | 372.79 | 499 / 504 |
thymus | 100% | 10731.62 | 653 / 653 | 99% | 245.39 | 598 / 605 |
skin | 100% | 14715.99 | 1809 / 1809 | 98% | 301.89 | 461 / 472 |
kidney | 100% | 9392.37 | 89 / 89 | 96% | 251.22 | 863 / 901 |
adrenal gland | 100% | 12246.21 | 258 / 258 | 94% | 306.57 | 217 / 230 |
liver | 89% | 3882.81 | 202 / 226 | 84% | 131.26 | 340 / 406 |
adipose | 100% | 13291.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16769.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 233.70 | 29 / 29 |
spleen | 100% | 7065.32 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 379.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 99.05 | 1 / 1 |
heart | 95% | 7695.72 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 209.22 | 75 / 80 |
peripheral blood | 74% | 5748.56 | 685 / 929 | 0% | 0 | 0 / 0 |
muscle | 73% | 2509.71 | 590 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0006605 | Biological process | protein targeting |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0034766 | Biological process | negative regulation of monoatomic ion transmembrane transport |
GO_0021762 | Biological process | substantia nigra development |
GO_0008104 | Biological process | protein localization |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YWHAQ |
Protein name | Uncharacterized protein YWHAQ 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta |
Synonyms | |
Description | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1. . |
Accessions | Q53RR5 P27348 ENST00000446619.1 E9PG15 ENST00000238081.8 Q53S41 ENST00000381844.8 |